$106 | SAVE $19 | Single User
$213 | SAVE $37 | Site License
$319 | SAVE $56 | Enterprise License

IDT Australia Limited - Financial and Strategic SWOT Analysis Review

IDT Australia Limited - Financial and Strategic SWOT Analysis Review
[Lowest Price Guaranteed: $106]

Published by Global Data: 24 Nov 2015 | 2666 | In Stock
Related Topics: Business , Drug , FDA , Financial , Generic Drugs

Introduction

IDT Australia Limited - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

IDT Australia Limited (IDT) is a pharmaceutical contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes in the post-discovery pharmaceutical life cycle. It has experience in the handling Cytotoxic API's, high potency API's, anti-cancer drugs, antibiotics, anti-psychotics, beta lactams and controlled drugs. IDT provides a wide range of services, which can be customized to meet the specific requirements of its customer. The company also provides specialist clinical trial labeling, packaging and dispensing services. IDT is headquartered in Boronia, Victoria, Australia.

IDT Australia Limited Key Recent Developments

Apr 13, 2015: FDA Confirms Change of Ownership of 23 US Generic Drugs and IDT Successfully Manufactures First Batch of Tablets

Jul 02, 2013: Imugene announces important progress in relation to its Linguet Ibuprofen formulation

Apr 04, 2013: IDT Names Paul MacLeman As CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for IDT Australia Limited - Financial and Strategic SWOT Analysis Review

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 5

    Section 1 - About the Company 6

    IDT Australia Limited - Key Facts 6

    IDT Australia Limited - Key Employees 7

    IDT Australia Limited - Key Employee Biographies 8

    IDT Australia Limited - Key Operational Employees 9

    IDT Australia Limited - Major Products and Services 10

    IDT Australia Limited - History 11

    IDT Australia Limited - Company Statement 12

    IDT Australia Limited - Locations And Subsidiaries 13

    Head Office 13

    Section 2 – Company Analysis 14

    IDT Australia Limited - Business Description 14

    IDT Australia Limited - Corporate Strategy 15

    IDT Australia Limited - SWOT Analysis 16

    SWOT Analysis - Overview 16

    IDT Australia Limited - Strengths 16

    Strength - Focused R&D Initiatives 16

    Strength - Manufacturing Facilities 16

    Strength - Experienced & Diversified Drug Developer 16

    IDT Australia Limited - Weaknesses 17

    Weakness - Negative Operating Margin 17

    Weakness - Working Capital Concerns 17

    IDT Australia Limited - Opportunities 18

    Opportunity - Demographic Trends 18

    Opportunity - Market Opportunity-Oncology 18

    Opportunity - Proprietary Product Acquisition 18

    IDT Australia Limited - Threats 19

    Threat - Increased Scrutiny on Drug Imports 19

    Threat - Competitive Pressures 19

    Threat - Uncertain R&D Outcomes 19

    IDT Australia Limited - Key Competitors 20

    Section 3 – Company Financial Ratios 21

    Financial Ratios - Capital Market Ratios 21

    Financial Ratios - Annual Ratios 22

    Performance Chart 23

    Financial Performance 23

    Financial Ratios - Interim Ratios 24

    Financial Ratios - Ratio Charts 25

    Section 4 – Company’s Lifesciences Financial Deals and Alliances 26

    IDT Australia Limited, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 26

    IDT Australia Limited, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 27

    IDT Australia Limited, Recent Deals Summary 28

    Section 5 – Appendix 29

    Methodology 29

    Ratio Definitions 29

    About GlobalData 33

    Contact Us 33

    Disclaimer 33

List Of Tables
in IDT Australia Limited - Financial and Strategic SWOT Analysis Review

List of Tables

IDT Australia Limited, Key Facts 6

IDT Australia Limited, Key Employees 7

IDT Australia Limited, Key Employee Biographies 8

IDT Australia Limited, Key Operational Employees 9

IDT Australia Limited, Major Products and Services 10

IDT Australia Limited, History 11

IDT Australia Limited, Key Competitors 20

IDT Australia Limited, Ratios based on current share price 21

IDT Australia Limited, Annual Ratios 22

IDT Australia Limited, Interim Ratios 24

IDT Australia Limited, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 26

IDT Australia Limited, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 27

IDT Australia Limited, Recent Deals Summary 28

Currency Codes 29

Capital Market Ratios 29

Equity Ratios 30

Profitability Ratios 30

Cost Ratios 31

Liquidity Ratios 31

Leverage Ratios 32

Efficiency Ratios 32

List Of Figures, Charts and Diagrams
in IDT Australia Limited - Financial and Strategic SWOT Analysis Review

List of Figures

IDT Australia Limited, Performance Chart (2011 - 2015) 23

IDT Australia Limited, Ratio Charts 25

IDT Australia Limited, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 26

IDT Australia Limited, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 27

Additional Details

Publisher

Global Data

Publisher Information

Reference

2666 | GDPH59177FSA

Number of Pages

33

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! IDT Australia Limited (IDT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryIDT Australia Limited (IDT) is a pharmaceutical contract manufacturing company that specializ...
24 Aug 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Specialised Therapeutics Australia Pty. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummarySpecialised Therapeutics Australia Pty. Ltd. (STA) is a bio-pharmaceutical company that devel...
12 May 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Novotech (Australia) Pty Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNovotech (Australia) Pty Limited (Novotech) is a full service contract research organization ...
11 May 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! IDT Australia Limited (IDT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryIDT Australia Limited (IDT) is a pharmaceutical contract manufacturing company that specializ...
15 Apr 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Specialised Therapeutics Australia Pty. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummarySpecialised Therapeutics Australia Pty. Ltd. (STA) is a pharmaceutical company that develops ...
16 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Novotech (Australia) Pty Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNovotech (Australia) Pty Limited (Novotech) is a full service contract research organization ...
15 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! IDT Australia Limited (IDT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryIDT Australia Limited (IDT) is a pharmaceutical contract manufacturing company that specializ...
04 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Australia Shoulder Replacement Procedures Outlook to 2021
Australia Shoulder Replacement Procedures Outlook to 2021SummaryGlobalData’s new report, "Australia ...
01 Oct 2015 by Global Data USD $850 (normally
USD $1,000)
More Info
SAVE 15% today! Australia Hip Replacement Procedures Outlook to 2021
Australia Hip Replacement Procedures Outlook to 2021SummaryGlobalData’s new report, "Australia Hip R...
11 Sep 2015 by Global Data USD $850 (normally
USD $1,000)
More Info
SAVE 15% today! Australia Knee Replacement Procedures Outlook to 2021
Australia Knee Replacement Procedures Outlook to 2021SummaryGlobalData’s new report, "Australia Knee...
11 Sep 2015 by Global Data USD $850 (normally
USD $1,000)
More Info

This report is published by Global Data

Download Free Report Summary PDF

IDT Australia Limited - Financial and Strategic SWOT Analysis Review | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...